The 6 most recent market catalysts affecting $BG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 10, 2026
Geopolitical Risk
Bearish
Impact 65
Bunge Says As A Result Of Morning Attacks In Dnipro, Ukraine, On September 10, A Section Of Our Facility Was Impacted; No Employees Were Injured In Dnipro Attack, We Will Continue To Monitor And Assess The Situation
Bunge's 8-K filing discloses that a section of its facility in Dnipro, Ukraine, was impacted by recent attacks. While no employees were injured, the damage to infrastructure in a k…
Sep 1, 2026
Corporate Catalyst
Neutral
Impact 65
Bunge Global Announces Deal To Sell Rio Vermelho And Nova Unialco Sugarcane Mills In São Paulo, Brazil To COFCO International; Terms Not Disclosed
This deal represents a strategic move for Bunge, likely aimed at streamlining its operations and potentially reducing debt or reallocating capital to more profitable ventures. For …
Aug 5, 2026
Geopolitical Risk
Bearish
Impact 75
'US suspends imports from Mexico's largest avocado producer' - AFP News Agency
The AFP news report, cited in the filing, details the US suspension of avocado imports from Mexico's largest producer due to security issues. This is a significant geopolitical and…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 75
Bunge shares are trading lower. The company reported Q2 financial results.
The headline directly points to Bunge's Q2 financial results as the cause for its stock trading lower, making this a clear corporate catalyst. The impact score is significant becau…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 75
Bunge Global Raises FY2026 Adj EPS Guidance from $9.00-$9.50 to $9.25-$9.75 vs $9.40 Est
Bunge Global (BG) has raised its adjusted EPS guidance for fiscal year 2026 from $9.00-$9.50 to $9.25-$9.75, which is now above the analyst consensus of $9.40. This upward revision…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 92
Bunge Q2 Adj. EPS $2.00 Beats $1.95 Estimate, Sales $24.041B Beat $22.817B Estimate
Bunge announced Q2 adjusted EPS of $2.00, surpassing the $1.95 consensus by 2.56%, and sales of $24.041 billion, beating the $22.817 billion estimate by 5.37%. This represents a su…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.